The Latest Breaking News from Illumina

Analyst Ratings For Illumina

Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter:

Benzinga · Mar 29, 2022

Illumina Launches Multiple-Gene Diagnostic Test For Cancer Patients

Illumina Inc (NASDAQ: ILMN) has launched TruSight Oncology (TSO) Comprehensive (EU), a 

Benzinga · Mar 15, 2022

Illumina vs. Qiagen: Which Diagnostics & Research Stock is a Better Buy?

The diagnostics and research industry has grown substantially over the past few years with the integration of advanced technologies and impressive breakthroughs in the early diagnosis of chronic diseases. Given the growing investments in this industry, prominent companies Illumina (ILMN) and Qiagen (QGEN) are well-positioned to benefit. Let’s find out…

StockNews.com · Feb 25, 2022

Illumina: Q4 Earnings Insights

Illumina (NASDAQ:ILMN) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Illumina beat estimated earnings by 53.06%, reporting an EPS of $0.75 versus an estimate of $0.49.

Benzinga · Feb 10, 2022